Trifluridine–tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study-Reference-Cited by-同舟云学术

Trifluridine–tipiracil plus bevacizumab versus capecitabine plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer ineligible for intensive therapy (SOLSTICE): a randomised, open-label phase 3 study

Published:2023-02 Issue:2 Volume:8 Page:133-144
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

André Thierry,Falcone Alfredo,Shparyk Yaroslav,Moiseenko Fedor,Polo-Marques Eduardo,Csöszi Tibor,Campos-Bragagnoli Arinilda,Liposits Gabor,Chmielowska Ewa,Aubel Paul,Martín Lourdes,Fougeray Ronan,Amellal Nadia,Saunders Mark P

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations;Papamichael;Ann Oncol,2009

3. Treatment of colorectal cancer in the elderly;Millan;World J Gastrointest Oncol,2015

4. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

5. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial;Seymour;Lancet,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-06

2. Updates on the Management of Colorectal Cancer in Older Adults;Cancers;2024-05-10

3. Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies;Journal of Cancer Research and Clinical Oncology;2024-05-08

4. Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study;Journal of Gastrointestinal Oncology;2024-04

5. Sunglasses for Sunlight: Considerations on New Treatment Opportunities for Refractory Colorectal Cancer;Cancers;2024-03-29